BioAge Labs, Inc.
BIOA
$4.51
-$0.10-2.17%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -66.79% | 38.81% | 9.73% | -72.35% | -4.53% |
Total Depreciation and Amortization | 56.76% | -21.28% | 23.68% | -22.45% | 48.48% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 8.59% | 29.55% | 7.02% | 30.75% | -15.05% |
Change in Net Operating Assets | 76.27% | -155.46% | 117.97% | 258.27% | 16.23% |
Cash from Operations | -15.01% | -237.93% | 65.59% | 5.39% | -0.70% |
Capital Expenditure | 62.68% | -1,538.46% | 91.48% | -771.43% | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 80.04% | -- | -- | -- | -- |
Cash from Investing | 79.94% | -299,853.85% | 91.48% | -771.43% | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Issuance of Common Stock | -- | -- | -85.76% | 45,914.69% | 13,966.67% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -100.00% | -- | -100.00% |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | 51.04% | -94.12% | -160.76% |
Cash from Financing | 0.00% | -106.02% | -86.94% | 8,088.40% | -101.42% |
Foreign Exchange rate Adjustments | -283.33% | -108.76% | 336.21% | -241.18% | -189.47% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 61.64% | -587.36% | -88.67% | 1,062.62% | -111.96% |